Akebia Therapeutics (AKBA) Amortization - Intangibles (2019 - 2024)
Historic Amortization - Intangibles for Akebia Therapeutics (AKBA) over the last 6 years, with Q4 2024 value amounting to $9.0 million.
- Akebia Therapeutics' Amortization - Intangibles changed 0.0% to $9.0 million in Q4 2024 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 7500.21%. This contributed to the annual value of $36.0 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q4 2024, Akebia Therapeutics' Amortization - Intangibles is $9.0 million, which was down 0.0% from $9.0 million recorded in Q3 2024.
- Over the past 5 years, Akebia Therapeutics' Amortization - Intangibles peaked at $9.1 million during Q2 2020, and registered a low of $6.1 million during Q3 2020.
- Its 5-year average for Amortization - Intangibles is $8.8 million, with a median of $9.0 million in 2021.
- Its Amortization - Intangibles has fluctuated over the past 5 years, first tumbled by 3290.85% in 2020, then surged by 4757.62% in 2021.
- Over the past 5 years, Akebia Therapeutics' Amortization - Intangibles (Quarter) stood at $8.3 million in 2020, then rose by 8.42% to $9.0 million in 2021, then changed by 0.0% to $9.0 million in 2022, then changed by 0.0% to $9.0 million in 2023, then changed by 0.0% to $9.0 million in 2024.
- Its Amortization - Intangibles was $9.0 million in Q4 2024, compared to $9.0 million in Q3 2024 and $9.0 million in Q2 2024.